Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$2.52 - $3.63 $75,600 - $108,900
-30,000 Reduced 60.0%
20,000 $61,000
Q4 2023

Feb 08, 2024

BUY
$1.69 - $2.54 $84,500 - $127,000
50,000 New
50,000 $125,000
Q4 2021

Feb 14, 2022

SELL
$3.11 - $4.61 $775,058 - $1.15 Million
-249,215 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$2.65 - $4.62 $572,670 - $998,391
-216,102 Reduced 46.44%
249,215 $1.07 Million
Q2 2021

Aug 13, 2021

SELL
$2.5 - $3.51 $53,500 - $75,114
-21,400 Reduced 4.4%
465,317 $1.41 Million
Q1 2021

May 04, 2021

BUY
$3.14 - $4.84 $67,196 - $103,576
21,400 Added 4.6%
486,717 $1.62 Million
Q4 2020

Feb 08, 2021

SELL
$2.76 - $4.97 $20,236 - $36,440
-7,332 Reduced 1.55%
465,317 $1.65 Million
Q3 2020

Nov 03, 2020

SELL
$1.75 - $6.2 $6.75 Million - $23.9 Million
-3,858,371 Reduced 89.09%
472,649 $1.48 Million
Q1 2020

May 11, 2020

BUY
$1.01 - $3.42 $3.44 Million - $11.6 Million
3,404,820 Added 367.61%
4,331,020 $4.37 Million
Q4 2019

Feb 11, 2020

BUY
$0.87 - $2.89 $805,794 - $2.68 Million
926,200 New
926,200 $2.58 Million

Others Institutions Holding ABUS

About Arbutus Biopharma Corp


  • Ticker ABUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,951,008
  • Market Cap $478M
  • Description
  • Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...
More about ABUS
Track This Portfolio

Track Cowen And Company, LLC Portfolio

Follow Cowen And Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen And Company, LLC with notifications on news.